or
forgot password

    • cancer clinical trials in spokane, WA

    • Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of Osteosarcoma
    Providence Cancer Center at Sacred Heart Medical Center
    Spokane, Washington 99220-2555
    Metastatic Cancer, Sarcoma
    S0222: Tirapazamine Combined With Chemo and RT in Limited-Stage Small Cell Lung Cancer
    Cancer Care Northwest - Spokane South
    Spokane, Washington 99202
    Lung Cancer
    Study of ILX651 in Patients With Inoperable Locally Advanced or Metastatic Melanoma
    US Oncology / Cancer Care Northwest
    Spokane, Washington 99218
    Melanoma
    S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
    Cancer Care Northwest - Spokane South
    Spokane, Washington 99202
    Sarcoma
    Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen
    Cancer Care Northwest-North
    Spokane, Washington 99218
    Prostate Cancer, Hormone Refractory Prostate Cancer
    Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma
    Providence Cancer Center at Sacred Heart Medical Center
    Spokane, Washington 99220-2555
    Lymphoma
    SR34006 Compared to Placebo in Patients Who Have Completed 6 Months of Treatment for Symptomatic Pulmonary Embolism or Deep Vein Thrombosis
    Sacred Heart Medical Center

    Trial Locations
    Sacred Heart Medical Center
    Pulmonary Specialists/Spokane Respiratory Consultants
    Pulmonary Embolism, Deep Vein Thrombosis
    A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer
    Cancer Care Northwest
    Spokane, Washington 99202
    Non-Small Cell Lung Cancer
    A Pilot Study of OSI-461 in Patients With Chronic Lymphocytic Leukemia (CLL)
    Cancer Care Northwest
    Spokane, Washington 99202
    Chronic Lymphocytic Leukemia
    Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma
    Providence Sacred Heart Medical Center and Children's Hospital
    Spokane, Washington 99204
    Adult Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma, Embryonal-botryoid Childhood Rhabdomyosarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma
    S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer
    Providence Cancer Center at Sacred Heart Medical Center

    Trial Locations
    Providence Cancer Center at Sacred Heart Medical Center
    Cancer Care Northwest - Spokane South
    Providence Cancer Center at Holy Family Hospital
    Rockwood Clinic Cancer Treatment Center
    Pancreatic Cancer
    Study of ILX651 in Patients With Hormone-Refractory Prostate Cancer Previously Treated With Docetaxel
    Cancer Care Northwest
    Spokane, Washington 99202
    Hormone-Refractory Prostate Cancer
    hu14.18-Interleukin-2 Fusion Protein in Treating Young Patients With Recurrent or Refractory Neuroblastoma
    Providence Cancer Center at Sacred Heart Medical Center
    Spokane, Washington 99220-2555
    Neuroblastoma
    Study of Talabostat and Cisplatin in Advanced Melanoma
    Cancer Care Northwest Research
    Spokane, Washington 99218
    Melanoma, Skin Cancer
    S0342: Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Providence Cancer Center at Sacred Heart Medical Center

    Trial Locations
    Providence Cancer Center at Sacred Heart Medical Center
    Cancer Care Northwest - Spokane South
    Providence Cancer Center at Holy Family Hospital
    Lung Cancer
    Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-Small Cell Lung Cancer (NSCLC)
    Cancer Care Northwest
    Spokane, Washington 99202
    Carcinoma, Non-Small-Cell Lung
    Onercept in the Treatment and Re-Treatment of Subjects With Moderate to Severe Plaque Psoriasis
    Rockwood Clinic, PS
    Spokane, Washington 99220
    Psoriatic Arthritis
    S0415 Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
    Cancer Care Northwest - Spokane South
    Spokane, Washington 99202
    Esophageal Cancer
    S0344 Intralesional Resection in Treating Patients With Chondrosarcoma of the Bone
    Cancer Care Northwest - Spokane South
    Spokane, Washington 99202
    Sarcoma
    A Study to Evaluate Psoriasis Outcomes and Safety Events in Patients With Chronic Moderate to Severe Plaque Psoriasis (RESPONSE)
    Northwest Dermatology

    Trial Locations
    Northwest Dermatology
    Spokane Dermatology Clinic
    Psoriasis
    Alternative Dosing Regimens of Subcutaneous Azacitidine for Myelodysplastic Syndromes
    Cancer Care Northwest
    Spokane, Washington 99202
    Myelodysplastic Syndromes
    The Plenaxis® Experience Study
    Roger D. Fincher, MD
    Spokane, Washington 99202
    Prostate Cancer
    S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
    Cancer Care Northwest - Spokane South
    Spokane, Washington 99202
    Melanoma (Skin)
    S0430 Cyclophosphamide and Capecitabine in Treating Women With Stage IV Breast Cancer
    Cancer Care Northwest - Spokane South
    Spokane, Washington 99202
    Breast Cancer
    S0423 Pemetrexed Disodium in Treating Patients With Recurrent and Unresectable or Metastatic Chondrosarcoma
    Cancer Care Northwest - Spokane South
    Spokane, Washington 99202
    Sarcoma
    Topotecan, G-CSF, and Radiation Therapy in Treating Young Patients With Newly Diagnosed Brain Stem Glioma
    Providence Cancer Center at Sacred Heart Medical Center
    Spokane, Washington 99220-2555
    Brain and Central Nervous System Tumors
    S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
    Cancer Care Northwest - Spokane South
    Spokane, Washington 99202
    Esophageal Cancer
    Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer
    Providence Cancer Center at Sacred Heart Medical Center

    Trial Locations
    Providence Cancer Center at Sacred Heart Medical Center
    Providence Cancer Center at Holy Family Hospital
    Lung Cancer
    Trial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the Pancreas
    Cancer Care Northwest
    Spokane, Washington 99202
    Pancreatic Cancer, Neoplasm Metastasis, Adenocarcinoma
    S0417 Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
    Cancer Care Northwest - Spokane South
    Spokane, Washington 99202
    Multiple Myeloma
    Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy
    Deaconess Medical Center
    Spokane, Washington 99210-0248
    Prostate Cancer, Osteoporosis, Fractures
    Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's Disease
    Site Ref # / Investigator 1850
    Spokane, Washington 99204
    Crohn's Disease
    S0505 Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas
    Providence Cancer Center at Sacred Heart Medical Center

    Trial Locations
    Providence Cancer Center at Sacred Heart Medical Center
    Cancer Care Northwest - Spokane South
    Providence Cancer Center at Holy Family Hospital
    Sarcoma
    Extension Study of ACTIQ Treatment for Children and Adolescents With Breakthrough Pain
    Sacred Heart Medical Center
    Spokane, Washington 99204
    Pain, Cancer, Sickle Cell Anemia, Severe Burns
    Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy
    Cancer Care Northwest Research

    Trial Locations
    Cancer Care Northwest Research
    Jay L. Wittenkeller, MD
    Carcinoma, Non-Small Cell Lung
    Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer
    Cancer Care Northwest-South
    Spokane, Washington 99202
    Colorectal Cancer Metastatic
    Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer
    Gersh, Robert
    Spokane, Washington 99202
    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms
    S0526: Pemetrexed Disodium in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
    Cancer Care Northwest - Spokane South
    Spokane, Washington 99202
    Lung Cancer
    Pemetrexed Disodium and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
    Cancer Care Northwest - Spokane South
    Spokane, Washington 99202
    Lung Cancer
    Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer
    Providence Sacred Heart Medical Center and Children's Hospital
    Spokane, Washington 99204
    Stage I Lymphoepithelioma of the Nasopharynx, Stage I Squamous Cell Carcinoma of the Nasopharynx, Stage II Lymphoepithelioma of the Nasopharynx, Stage II Squamous Cell Carcinoma of the Nasopharynx, Stage III Lymphoepithelioma of the Nasopharynx, Stage III Squamous Cell Carcinoma of the Nasopharynx, Stage IV Lymphoepithelioma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Nasopharynx
    Sorafenib With Either Temsirolimus or Tipifarnib in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed By Surgery
    Cancer Care Northwest - Spokane South
    Spokane, Washington 99202
    Recurrent Melanoma, Stage IV Melanoma
    Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy
    Cancer Care Northwest
    Spokane, Washington 99202
    Carcinoma, Non-Small-Cell Lung, Lung Cancer, Neoplasms, Lung, Neoplasms, Pulmonary
    Doxil & Carboplatin Plus HER2+ in Metastatic Breast Cancer
    Cancer Care Northwest-North
    Spokane, Washington 99218
    Metastatic Breast Cancer
    Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer (Groups I and II Closed to Accrual as of 4/29/2009)
    Cancer Care Northwest - Spokane South
    Spokane, Washington 99202
    Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer